Managing Dental Pharmacology
Guides dental prescribing with evidence-based local anesthetic selection, antibiotic stewardship, analgesic protocols, and drug interaction management for safe dental therapeutics.
Why This Skill Exists
Dentists write approximately 10% of all outpatient antibiotic prescriptions in the United States, and dental prescriptions are a documented contributor to antibiotic resistance and opioid misuse. Inappropriate antibiotic prescribing for conditions that require drainage (not drugs), excessive opioid prescriptions for extractions manageable with NSAIDs, and failure to screen for drug interactions with local anesthetic vasoconstrictors represent persistent quality gaps.
Local anesthetic failure is the most common reason patients report negative dental experiences, yet selecting the right agent, concentration, and vasoconstrictor for each clinical scenario is often done by habit rather than pharmacologic reasoning. This skill provides structured protocols for local anesthesia, antibiotic prescribing, pain management, and drug interaction screening.
Checkpoint A: Pre-Prescribing Intake (Mandatory)
- What procedure is planned, and what level of anesthesia and post-operative pain is expected?
- What is the patient's complete medication list, including OTC and herbal supplements?
- Does the patient have documented drug allergies, with specific reaction type (true allergy, adverse reaction, intolerance)?
- What is the patient's relevant medical history (cardiac, hepatic, renal, adrenal, psychiatric)?
- Is the patient pregnant or breastfeeding?
- What is the patient's weight (for pediatric dosing or maximum dose calculations)?
- Has the patient had adverse reactions to local anesthetics or sedatives previously?
- Is there a substance use history relevant to prescribing (opioid use disorder, benzodiazepine dependence)?
Documents to Request
- Current medication list verified against pharmacy database
- Medical history with allergy documentation (reaction type, severity, date)
- Most recent hepatic and renal function tests (if impaired function suspected)
- Previous dental records documenting anesthetic history and adverse events
- Prescription Drug Monitoring Program (PDMP) report (required by law in most states before prescribing controlled substances)
- Patient weight documentation (required for all pediatric patients and weight-based dosing)
Step 1: Local Anesthetic Selection
Available Dental Local Anesthetics
| Agent |
Concentration |
Vasoconstrictor |
Onset |
Duration (Pulpal) |
Duration (Soft Tissue) |
Max Dose (Healthy Adult) |
| Lidocaine |
2% |
Epinephrine 1:100,000 |
2–3 min |
60 min |
3–5 hr |
7.0 mg/kg (500 mg abs max) |
| Articaine |
4% |
Epinephrine 1:100,000 |
1–2 min |
60–75 min |
3–6 hr |
7.0 mg/kg (500 mg abs max) |
| Articaine |
4% |
Epinephrine 1:200,000 |
1–2 min |
45–60 min |
2–5 hr |
7.0 mg/kg |
| Mepivacaine |
3% |
None |
1.5–2 min |
20–40 min (infiltration) |
2–3 hr |
6.6 mg/kg (400 mg abs max) |
| Mepivacaine |
2% |
Levonordefrin 1:20,000 |
1.5–2 min |
60 min |
3–5 hr |
6.6 mg/kg |
| Bupivacaine |
0.5% |
Epinephrine 1:200,000 |
6–10 min |
90–180 min |
4–9 hr |
1.3 mg/kg (90 mg abs max) |
| Prilocaine |
4% |
Epinephrine 1:200,000 |
2–4 min |
60–90 min |
3–8 hr |
8.0 mg/kg (600 mg abs max) |
Selection Algorithm
- Default choice: Lidocaine 2% with epinephrine 1:100,000 — well-studied, reliable, FDA pregnancy category B
- When faster onset or mandibular buccal infiltration is needed: Articaine 4% (superior bone penetration due to thiophene ring)
- When vasoconstrictor must be avoided or minimized: Mepivacaine 3% plain (short procedures) or prilocaine 4% plain
- When prolonged post-operative analgesia is desired: Bupivacaine 0.5% with epinephrine (surgical extractions, post-op pain control)
- Pediatric patients: Calculate maximum dose by weight BEFORE beginning; use shortest-acting agent sufficient for the procedure
Vasoconstrictor Precautions
| Condition |
Epinephrine Guidance |
| Controlled hypertension (BP < 160/100) |
Standard epinephrine doses acceptable; aspirate carefully |
| Uncontrolled hypertension (BP > 180/110) |
Defer elective treatment; if emergent, limit to 2 cartridges of 1:100,000 |
| Unstable angina or recent MI (< 6 months) |
Avoid elective treatment; emergent: use minimal epinephrine with cardiac monitoring |
| Hyperthyroidism (uncontrolled) |
Limit epinephrine; thyrotoxic patients have exaggerated catecholamine response |
| MAO inhibitor or tricyclic antidepressant use |
Epinephrine safe in dental doses (ADA/AHA consensus); avoid levonordefrin; aspirate carefully |
| Cocaine use (within 24 hours) |
ABSOLUTE CONTRAINDICATION to epinephrine — risk of hypertensive crisis, MI, stroke |
| Pheochromocytoma |
Avoid epinephrine — risk of hypertensive crisis |
Step 2: Antibiotic Prescribing — Stewardship Principles
When Antibiotics ARE Indicated in Dentistry
- Endocarditis prophylaxis: Per AHA guidelines (see medical integration skill)
- Acute spreading infection: Cellulitis, fascial space infection, Ludwig's angina — adjunct to I&D
- Pericoronitis with systemic signs: Fever, trismus, lymphadenopathy
- Acute necrotizing ulcerative gingivitis (ANUG): With systemic symptoms
- Post-surgical prophylaxis: Implant placement, bone grafting, immunocompromised patients (per clinical judgment)
When Antibiotics Are NOT Indicated
- Irreversible pulpitis (treatment: pulpectomy or extraction, not antibiotics)
- Localized periapical abscess (treatment: I&D or endodontic access, not antibiotics alone)
- Dry socket / alveolar osteitis (treatment: local irrigation and dressing)
- Chronic periodontitis without acute exacerbation (treatment: SRP)
- Routine prophylaxis before dental procedures in otherwise healthy patients
First-Line Dental Antibiotic Regimens
| Indication |
Drug |
Dose (Adult) |
Duration |
Notes |
| Odontogenic infection (first-line) |
Amoxicillin |
500 mg TID |
7 days |
Add metronidazole 500 mg TID if anaerobic coverage needed |
| Penicillin allergy (non-anaphylactic) |
Clindamycin |
300 mg QID |
7 days |
Monitor for C. difficile; warn patient |
| Penicillin allergy (anaphylactic) |
Azithromycin |
500 mg day 1, 250 mg days 2–5 |
5 days |
Less effective for odontogenic infections |
| Aggressive periodontitis adjunct |
Amoxicillin 500 mg + Metronidazole 500 mg |
TID |
8 days |
Adjunct to SRP, not replacement |
Step 3: Analgesic Protocols — Opioid-Sparing Approach
Evidence-Based Post-Operative Dental Pain Management
| Pain Level |
Recommended Regimen |
Notes |
| Mild (routine restorative, SRP) |
Ibuprofen 400 mg q6h PRN |
First-line; effective ceiling dose for analgesia |
| Moderate (simple extractions, endo) |
Ibuprofen 400–600 mg + Acetaminophen 500–1000 mg alternating q3h |
Superior to opioid combinations in RCTs |
| Moderate-severe (surgical extractions, implants) |
Ibuprofen 400 mg + Acetaminophen 500 mg simultaneously q6h |
Combination exceeds efficacy of hydrocodone/APAP |
| Severe (bone grafting, major oral surgery) |
Scheduled NSAID + APAP; opioid rescue only |
Limit opioid to 3 days maximum; prescribe lowest quantity |
NSAID Contraindications and Alternatives
- Renal impairment (GFR < 30): Avoid NSAIDs; use acetaminophen alone
- Active GI bleeding or ulcer history: Avoid NSAIDs or use with PPI cover; use acetaminophen alone
- Third trimester pregnancy: Contraindicated (risk of premature ductus closure); use acetaminophen
- Aspirin-exacerbated respiratory disease: Avoid all NSAIDs; use acetaminophen
- Anticoagulant therapy: NSAIDs increase bleeding risk; use acetaminophen preferentially; if NSAID needed, use short course with monitoring
Opioid Prescribing Rules
- Check the state PDMP before prescribing any opioid
- Prescribe the lowest effective quantity — typically ≤ 12 tablets for dental surgery
- Do not prescribe long-acting opioids (OxyContin, methadone) for acute dental pain
- Counsel the patient on storage, disposal, and risk of dependence
- Never co-prescribe benzodiazepines and opioids unless clinically essential with documented rationale
- Document the pain diagnosis justifying the opioid prescription in the chart
Step 4: Drug Interaction Screening
High-Risk Dental Drug Interactions
| Dental Drug |
Interacting Drug |
Risk |
Management |
| Epinephrine |
Cocaine (within 24h) |
Hypertensive crisis, MI |
Absolute contraindication; defer treatment |
| Epinephrine |
Non-selective beta blockers (propranolol) |
Hypertensive episode |
Limit epinephrine dose; monitor BP |
| NSAIDs |
Warfarin |
Increased INR, bleeding |
Short course only; monitor INR; prefer acetaminophen |
| NSAIDs |
Lithium |
Increased lithium levels |
Avoid if possible; monitor lithium level if used |
| NSAIDs |
Methotrexate |
Increased methotrexate toxicity |
Avoid concurrent use if high-dose methotrexate |
| Metronidazole |
Alcohol |
Disulfiram-like reaction |
Counsel patient; no alcohol during treatment + 48h after |
| Metronidazole |
Warfarin |
Increased INR |
Monitor INR; reduce warfarin dose if needed |
| Erythromycin/clarithromycin |
Statins, carbamazepine, warfarin |
CYP3A4 inhibition; toxicity |
Use azithromycin instead (minimal CYP interaction) |
| Clindamycin |
Neuromuscular blockers |
Prolonged paralysis |
Relevant for general anesthesia cases |
| Acetaminophen |
Warfarin (chronic APAP > 2g/day) |
Increased INR |
Use ≤ 2g/day; monitor INR |
Step 5: Special Population Prescribing
Pregnancy and Lactation
| Drug |
Pregnancy Safety |
Lactation Safety |
Notes |
| Lidocaine with epinephrine |
FDA Category B — preferred LA in pregnancy |
Compatible |
Safe at all trimesters |
| Acetaminophen |
Safe — first-line analgesic |
Compatible |
Do not exceed 3g/day |
| Ibuprofen |
Avoid in third trimester (Category D); Category B first/second |
Compatible in short courses |
Risk of premature ductus closure in third trimester |
| Amoxicillin |
Category B — safe |
Compatible |
First-line antibiotic in pregnancy |
| Clindamycin |
Category B — safe |
Compatible |
Alternative for penicillin allergy |
| Metronidazole |
Category B — safe for second/third trimester |
Compatible but may alter taste |
Historically avoided in first trimester; current evidence supports safety |
| Tetracyclines (doxycycline) |
Category D — contraindicated |
Avoid |
Tooth discoloration and enamel hypoplasia in fetus |
| Codeine/hydrocodone |
Category C — use only if benefit outweighs risk |
Codeine: avoid (ultra-rapid metabolizers produce excessive morphine) |
Prescribe rarely; limit to 48 hours |
| Benzodiazepines |
Category D — avoid if possible |
Avoid |
Neonatal withdrawal syndrome risk |
Renal Impairment
| Drug |
GFR > 50 |
GFR 10–50 |
GFR < 10 |
| Amoxicillin |
Normal dose |
Reduce frequency to BID |
Reduce to QD; supplement after dialysis |
| Metronidazole |
Normal dose |
Normal dose |
Reduce dose by 50% |
| NSAIDs |
Use with caution |
Avoid if possible |
Contraindicated |
| Acetaminophen |
Normal dose (max 3g/day) |
Normal dose (max 2g/day) |
Max 2g/day |
| Gabapentin |
Normal dose |
Reduce dose per GFR table |
100–300 mg post-dialysis |
Checkpoint B: Post-Prescribing Alignment (Mandatory)
- Has the maximum local anesthetic dose been calculated and documented for this patient?
- Is every prescribed antibiotic supported by a specific clinical indication (not "just in case")?
- Has the PDMP been checked before any controlled substance prescription?
- Have drug interactions been screened against the patient's full medication list?
- Has the patient been counseled on proper medication use, side effects, and disposal (for opioids)?
Quality Audit
| # |
Criterion |
Pass / Fail |
| 1 |
Local anesthetic selected with documented rationale for agent and vasoconstrictor choice |
|
| 2 |
Maximum dose calculated by weight for all pediatric patients |
|
| 3 |
Vasoconstrictor precautions applied per patient's medical/medication profile |
|
| 4 |
Antibiotics prescribed only for documented indications (not prophylactically for irreversible pulpitis or localized abscess) |
|
| 5 |
Antibiotic choice matches first-line guidelines for odontogenic infections |
|
| 6 |
NSAID + acetaminophen combination used as first-line post-operative analgesic |
|
| 7 |
Opioid prescribed only after PDMP check with limited quantity (≤ 12 tablets for dental procedures) |
|
| 8 |
No concurrent opioid + benzodiazepine prescription without documented clinical justification |
|
| 9 |
Drug interactions screened against full medication list |
|
| 10 |
Allergy documentation includes reaction type, not just "allergic" |
|
| 11 |
Pregnancy status checked before prescribing Category C/D/X drugs |
|
| 12 |
Patient counseled on medication use, side effects, and disposal |
|
| 13 |
Prescriptions documented in dental chart with indication, dose, quantity, and refills |
|
| 14 |
Antibiotic stewardship compliance tracked quarterly (indication, appropriateness, duration) |
|
Guidelines
- The ibuprofen + acetaminophen combination is more effective than any opioid combination for dental pain — prescribe it as default first-line
- Never prescribe antibiotics as a substitute for definitive dental treatment (I&D, pulpectomy, extraction)
- Articaine should not be used for inferior alveolar nerve blocks in pediatric patients due to higher reported paresthesia rates — use lidocaine for IAN blocks
- Verify that "penicillin allergy" is a true IgE-mediated allergy before defaulting to clindamycin — most reported penicillin allergies are not true allergies upon investigation
- Calculate and document the maximum anesthetic dose for every patient before beginning multi-quadrant treatment
- Metronidazole requires explicit alcohol avoidance counseling — document the warning in the chart
- Check the state PDMP before every controlled substance prescription — this is a legal requirement in the majority of US states
- Stay current with ADA antibiotic stewardship guidelines and CDC opioid prescribing recommendations; prescribing patterns are increasingly audited by dental boards
1---2name: managing-dental-pharmacology3description: Guides dental prescribing with local anesthetic selection, antibiotic prophylaxis, and pain management. Use when prescribing dental medications, selecting local anesthetics, or managing dental pain.4---5
6# Managing Dental Pharmacology
7
8Guides dental prescribing with evidence-based local anesthetic selection, antibiotic stewardship, analgesic protocols, and drug interaction management for safe dental therapeutics.
9
10## Why This Skill Exists
11
12Dentists write approximately 10% of all outpatient antibiotic prescriptions in the United States, and dental prescriptions are a documented contributor to antibiotic resistance and opioid misuse. Inappropriate antibiotic prescribing for conditions that require drainage (not drugs), excessive opioid prescriptions for extractions manageable with NSAIDs, and failure to screen for drug interactions with local anesthetic vasoconstrictors represent persistent quality gaps.
13
14Local anesthetic failure is the most common reason patients report negative dental experiences, yet selecting the right agent, concentration, and vasoconstrictor for each clinical scenario is often done by habit rather than pharmacologic reasoning. This skill provides structured protocols for local anesthesia, antibiotic prescribing, pain management, and drug interaction screening.
15
16---
17
18## Checkpoint A: Pre-Prescribing Intake (Mandatory)
19
201. What procedure is planned, and what level of anesthesia and post-operative pain is expected?
212. What is the patient's complete medication list, including OTC and herbal supplements?
223. Does the patient have documented drug allergies, with specific reaction type (true allergy, adverse reaction, intolerance)?
234. What is the patient's relevant medical history (cardiac, hepatic, renal, adrenal, psychiatric)?
245. Is the patient pregnant or breastfeeding?
256. What is the patient's weight (for pediatric dosing or maximum dose calculations)?
267. Has the patient had adverse reactions to local anesthetics or sedatives previously?
278. Is there a substance use history relevant to prescribing (opioid use disorder, benzodiazepine dependence)?
28
29### Documents to Request
30
31- Current medication list verified against pharmacy database
32- Medical history with allergy documentation (reaction type, severity, date)
33- Most recent hepatic and renal function tests (if impaired function suspected)
34- Previous dental records documenting anesthetic history and adverse events
35- Prescription Drug Monitoring Program (PDMP) report (required by law in most states before prescribing controlled substances)
36- Patient weight documentation (required for all pediatric patients and weight-based dosing)
37
38---
39
40## Step 1: Local Anesthetic Selection
41
42### Available Dental Local Anesthetics
43
44| Agent | Concentration | Vasoconstrictor | Onset | Duration (Pulpal) | Duration (Soft Tissue) | Max Dose (Healthy Adult) |
45|-------|-------------|-----------------|-------|-------------------|----------------------|------------------------|
46| Lidocaine | 2% | Epinephrine 1:100,000 | 2–3 min | 60 min | 3–5 hr | 7.0 mg/kg (500 mg abs max) |
47| Articaine | 4% | Epinephrine 1:100,000 | 1–2 min | 60–75 min | 3–6 hr | 7.0 mg/kg (500 mg abs max) |
48| Articaine | 4% | Epinephrine 1:200,000 | 1–2 min | 45–60 min | 2–5 hr | 7.0 mg/kg |
49| Mepivacaine | 3% | None | 1.5–2 min | 20–40 min (infiltration) | 2–3 hr | 6.6 mg/kg (400 mg abs max) |
50| Mepivacaine | 2% | Levonordefrin 1:20,000 | 1.5–2 min | 60 min | 3–5 hr | 6.6 mg/kg |
51| Bupivacaine | 0.5% | Epinephrine 1:200,000 | 6–10 min | 90–180 min | 4–9 hr | 1.3 mg/kg (90 mg abs max) |
52| Prilocaine | 4% | Epinephrine 1:200,000 | 2–4 min | 60–90 min | 3–8 hr | 8.0 mg/kg (600 mg abs max) |
53
54### Selection Algorithm
55
561. **Default choice**: Lidocaine 2% with epinephrine 1:100,000 — well-studied, reliable, FDA pregnancy category B
572. **When faster onset or mandibular buccal infiltration is needed**: Articaine 4% (superior bone penetration due to thiophene ring)
583. **When vasoconstrictor must be avoided or minimized**: Mepivacaine 3% plain (short procedures) or prilocaine 4% plain
594. **When prolonged post-operative analgesia is desired**: Bupivacaine 0.5% with epinephrine (surgical extractions, post-op pain control)
605. **Pediatric patients**: Calculate maximum dose by weight BEFORE beginning; use shortest-acting agent sufficient for the procedure
61
62### Vasoconstrictor Precautions
63
64| Condition | Epinephrine Guidance |
65|-----------|---------------------|
66| Controlled hypertension (BP < 160/100) | Standard epinephrine doses acceptable; aspirate carefully |
67| Uncontrolled hypertension (BP > 180/110) | Defer elective treatment; if emergent, limit to 2 cartridges of 1:100,000 |
68| Unstable angina or recent MI (< 6 months) | Avoid elective treatment; emergent: use minimal epinephrine with cardiac monitoring |
69| Hyperthyroidism (uncontrolled) | Limit epinephrine; thyrotoxic patients have exaggerated catecholamine response |
70| MAO inhibitor or tricyclic antidepressant use | Epinephrine safe in dental doses (ADA/AHA consensus); avoid levonordefrin; aspirate carefully |
71| Cocaine use (within 24 hours) | ABSOLUTE CONTRAINDICATION to epinephrine — risk of hypertensive crisis, MI, stroke |
72| Pheochromocytoma | Avoid epinephrine — risk of hypertensive crisis |
73
74---
75
76## Step 2: Antibiotic Prescribing — Stewardship Principles
77
78### When Antibiotics ARE Indicated in Dentistry
79
801. **Endocarditis prophylaxis**: Per AHA guidelines (see medical integration skill)
812. **Acute spreading infection**: Cellulitis, fascial space infection, Ludwig's angina — adjunct to I&D
823. **Pericoronitis with systemic signs**: Fever, trismus, lymphadenopathy
834. **Acute necrotizing ulcerative gingivitis (ANUG)**: With systemic symptoms
845. **Post-surgical prophylaxis**: Implant placement, bone grafting, immunocompromised patients (per clinical judgment)
85
86### When Antibiotics Are NOT Indicated
87
88- Irreversible pulpitis (treatment: pulpectomy or extraction, not antibiotics)
89- Localized periapical abscess (treatment: I&D or endodontic access, not antibiotics alone)
90- Dry socket / alveolar osteitis (treatment: local irrigation and dressing)
91- Chronic periodontitis without acute exacerbation (treatment: SRP)
92- Routine prophylaxis before dental procedures in otherwise healthy patients
93
94### First-Line Dental Antibiotic Regimens
95
96| Indication | Drug | Dose (Adult) | Duration | Notes |
97|-----------|------|-------------|----------|-------|
98| Odontogenic infection (first-line) | Amoxicillin | 500 mg TID | 7 days | Add metronidazole 500 mg TID if anaerobic coverage needed |
99| Penicillin allergy (non-anaphylactic) | Clindamycin | 300 mg QID | 7 days | Monitor for C. difficile; warn patient |
100| Penicillin allergy (anaphylactic) | Azithromycin | 500 mg day 1, 250 mg days 2–5 | 5 days | Less effective for odontogenic infections |
101| Aggressive periodontitis adjunct | Amoxicillin 500 mg + Metronidazole 500 mg | TID | 8 days | Adjunct to SRP, not replacement |
102
103---
104
105## Step 3: Analgesic Protocols — Opioid-Sparing Approach
106
107### Evidence-Based Post-Operative Dental Pain Management
108
109| Pain Level | Recommended Regimen | Notes |
110|-----------|-------------------|-------|
111| Mild (routine restorative, SRP) | Ibuprofen 400 mg q6h PRN | First-line; effective ceiling dose for analgesia |
112| Moderate (simple extractions, endo) | Ibuprofen 400–600 mg + Acetaminophen 500–1000 mg alternating q3h | Superior to opioid combinations in RCTs |
113| Moderate-severe (surgical extractions, implants) | Ibuprofen 400 mg + Acetaminophen 500 mg simultaneously q6h | Combination exceeds efficacy of hydrocodone/APAP |
114| Severe (bone grafting, major oral surgery) | Scheduled NSAID + APAP; opioid rescue only | Limit opioid to 3 days maximum; prescribe lowest quantity |
115
116### NSAID Contraindications and Alternatives
117
118- **Renal impairment (GFR < 30)**: Avoid NSAIDs; use acetaminophen alone
119- **Active GI bleeding or ulcer history**: Avoid NSAIDs or use with PPI cover; use acetaminophen alone
120- **Third trimester pregnancy**: Contraindicated (risk of premature ductus closure); use acetaminophen
121- **Aspirin-exacerbated respiratory disease**: Avoid all NSAIDs; use acetaminophen
122- **Anticoagulant therapy**: NSAIDs increase bleeding risk; use acetaminophen preferentially; if NSAID needed, use short course with monitoring
123
124### Opioid Prescribing Rules
125
1261. Check the state PDMP before prescribing any opioid
1272. Prescribe the lowest effective quantity — typically ≤ 12 tablets for dental surgery
1283. Do not prescribe long-acting opioids (OxyContin, methadone) for acute dental pain
1294. Counsel the patient on storage, disposal, and risk of dependence
1305. Never co-prescribe benzodiazepines and opioids unless clinically essential with documented rationale
1316. Document the pain diagnosis justifying the opioid prescription in the chart
132
133---
134
135## Step 4: Drug Interaction Screening
136
137### High-Risk Dental Drug Interactions
138
139| Dental Drug | Interacting Drug | Risk | Management |
140|-------------|-----------------|------|------------|
141| Epinephrine | Cocaine (within 24h) | Hypertensive crisis, MI | Absolute contraindication; defer treatment |
142| Epinephrine | Non-selective beta blockers (propranolol) | Hypertensive episode | Limit epinephrine dose; monitor BP |
143| NSAIDs | Warfarin | Increased INR, bleeding | Short course only; monitor INR; prefer acetaminophen |
144| NSAIDs | Lithium | Increased lithium levels | Avoid if possible; monitor lithium level if used |
145| NSAIDs | Methotrexate | Increased methotrexate toxicity | Avoid concurrent use if high-dose methotrexate |
146| Metronidazole | Alcohol | Disulfiram-like reaction | Counsel patient; no alcohol during treatment + 48h after |
147| Metronidazole | Warfarin | Increased INR | Monitor INR; reduce warfarin dose if needed |
148| Erythromycin/clarithromycin | Statins, carbamazepine, warfarin | CYP3A4 inhibition; toxicity | Use azithromycin instead (minimal CYP interaction) |
149| Clindamycin | Neuromuscular blockers | Prolonged paralysis | Relevant for general anesthesia cases |
150| Acetaminophen | Warfarin (chronic APAP > 2g/day) | Increased INR | Use ≤ 2g/day; monitor INR |
151
152---
153
154## Step 5: Special Population Prescribing
155
156### Pregnancy and Lactation
157
158| Drug | Pregnancy Safety | Lactation Safety | Notes |
159|------|-----------------|-----------------|-------|
160| Lidocaine with epinephrine | FDA Category B — preferred LA in pregnancy | Compatible | Safe at all trimesters |
161| Acetaminophen | Safe — first-line analgesic | Compatible | Do not exceed 3g/day |
162| Ibuprofen | Avoid in third trimester (Category D); Category B first/second | Compatible in short courses | Risk of premature ductus closure in third trimester |
163| Amoxicillin | Category B — safe | Compatible | First-line antibiotic in pregnancy |
164| Clindamycin | Category B — safe | Compatible | Alternative for penicillin allergy |
165| Metronidazole | Category B — safe for second/third trimester | Compatible but may alter taste | Historically avoided in first trimester; current evidence supports safety |
166| Tetracyclines (doxycycline) | Category D — contraindicated | Avoid | Tooth discoloration and enamel hypoplasia in fetus |
167| Codeine/hydrocodone | Category C — use only if benefit outweighs risk | Codeine: avoid (ultra-rapid metabolizers produce excessive morphine) | Prescribe rarely; limit to 48 hours |
168| Benzodiazepines | Category D — avoid if possible | Avoid | Neonatal withdrawal syndrome risk |
169
170### Renal Impairment
171
172| Drug | GFR > 50 | GFR 10–50 | GFR < 10 |
173|------|----------|-----------|----------|
174| Amoxicillin | Normal dose | Reduce frequency to BID | Reduce to QD; supplement after dialysis |
175| Metronidazole | Normal dose | Normal dose | Reduce dose by 50% |
176| NSAIDs | Use with caution | Avoid if possible | Contraindicated |
177| Acetaminophen | Normal dose (max 3g/day) | Normal dose (max 2g/day) | Max 2g/day |
178| Gabapentin | Normal dose | Reduce dose per GFR table | 100–300 mg post-dialysis |
179
180---
181
182## Checkpoint B: Post-Prescribing Alignment (Mandatory)
183
1841. Has the maximum local anesthetic dose been calculated and documented for this patient?
1852. Is every prescribed antibiotic supported by a specific clinical indication (not "just in case")?
1863. Has the PDMP been checked before any controlled substance prescription?
1874. Have drug interactions been screened against the patient's full medication list?
1885. Has the patient been counseled on proper medication use, side effects, and disposal (for opioids)?
189
190---
191
192## Quality Audit
193
194| # | Criterion | Pass / Fail |
195|---|-----------|-------------|
196| 1 | Local anesthetic selected with documented rationale for agent and vasoconstrictor choice | |
197| 2 | Maximum dose calculated by weight for all pediatric patients | |
198| 3 | Vasoconstrictor precautions applied per patient's medical/medication profile | |
199| 4 | Antibiotics prescribed only for documented indications (not prophylactically for irreversible pulpitis or localized abscess) | |
200| 5 | Antibiotic choice matches first-line guidelines for odontogenic infections | |
201| 6 | NSAID + acetaminophen combination used as first-line post-operative analgesic | |
202| 7 | Opioid prescribed only after PDMP check with limited quantity (≤ 12 tablets for dental procedures) | |
203| 8 | No concurrent opioid + benzodiazepine prescription without documented clinical justification | |
204| 9 | Drug interactions screened against full medication list | |
205| 10 | Allergy documentation includes reaction type, not just "allergic" | |
206| 11 | Pregnancy status checked before prescribing Category C/D/X drugs | |
207| 12 | Patient counseled on medication use, side effects, and disposal | |
208| 13 | Prescriptions documented in dental chart with indication, dose, quantity, and refills | |
209| 14 | Antibiotic stewardship compliance tracked quarterly (indication, appropriateness, duration) | |
210
211---
212
213## Guidelines
214
215- The ibuprofen + acetaminophen combination is more effective than any opioid combination for dental pain — prescribe it as default first-line
216- Never prescribe antibiotics as a substitute for definitive dental treatment (I&D, pulpectomy, extraction)
217- Articaine should not be used for inferior alveolar nerve blocks in pediatric patients due to higher reported paresthesia rates — use lidocaine for IAN blocks
218- Verify that "penicillin allergy" is a true IgE-mediated allergy before defaulting to clindamycin — most reported penicillin allergies are not true allergies upon investigation
219- Calculate and document the maximum anesthetic dose for every patient before beginning multi-quadrant treatment
220- Metronidazole requires explicit alcohol avoidance counseling — document the warning in the chart
221- Check the state PDMP before every controlled substance prescription — this is a legal requirement in the majority of US states
222- Stay current with ADA antibiotic stewardship guidelines and CDC opioid prescribing recommendations; prescribing patterns are increasingly audited by dental boards
CaseMark